Ophthalmic and Otic Disorders Pharmacology

Ophthalmic Anti-Infectives: Mechanism and Properties

  • Ophthalmic anti-infectives are pharmacological agents used to treat ocular infections and can be classified based on their action as either bacteriostatic (inhibiting growth) or bactericidal (killing bacteria).
  • Pharmacokinetics: These medications generally penetrate only the ocular fluid and tissues. There is minimal systemic absorption associated with these topical applications.
  • Precautions: Providers must use caution because these agents can trigger hypersensitivity reactions.

Adverse Drug Reactions (ADRs) and Specific Ophthalmic Agents

  • General ADR: The most common adverse reaction to ophthalmic anti-infectives is local irritation.
  • Super Infection: Prolonged use of these medications can lead to a super infection.
  • Bacitracin: Specifically known to cause blurred vision.
  • Aminoglycosides: Use can lead to localized ocular toxicity.
  • Fluoroquinolones: These may cause a white crystalline precipitate to form in the superficial portion of the cornea.
  • Reference Materials: Students are directed to study the following in their textbook:   - Table 26126-1: Lists ophthalmic anti-infectives, drug interactions, possible effects, and clinical implications.   - Table 26326-3: Discusses indications, forms, doses, and specific comments regarding each anti-infective ophthalmic medication.

Clinical Indications for Ophthalmic Anti-Infectives

  • Chlamydia Conjunctivitis in Newborns:   - Shortly after birth, newborns typically receive Erythromycin eye ointment in both eyes to prevent Chlamydial conjunctivitis, which can lead to blindness.   - If a newborn develops the infection, it is treated with systemic Erythromycin.
  • Bacterial Conjunctivitis:   - Presentation: Symptoms include erythema, purulent discharge, itching, burning, and matted eyelashes (often referred to as "mad eyelashes").   - Demographics: While it can affect any individual of any age, it is more common in children between the ages of 33 months and 88 years.   - Treatment: Typically managed with topical ophthalmic anti-infective medications.
  • Blepharitis:   - Defined as acute or chronic inflammation of the eyelash follicles and the meibomian glands of the eyelids.   - Treatment Protocol: Instruct the patient to scrub eyelashes with a gentle "no-tear" soap to clear follicles and glands. Treatment may also include Erythromycin ophthalmic ointment.
  • Hordeolums (Styes):   - These are treated with antibiotic eye drops or ointments.
  • Viral Conjunctivitis:   - Anti-infectives may be used if indicated; however, if Herpes is suspected, the patient must be referred immediately to an ophthalmologist.

Patient Education for Ophthalmic Anti-Infectives

  • Administration Techniques:   - Prevent contamination by not touching the eye dropper to the eye.   - Wash hands thoroughly both before and after administration.   - Proper instruction on how to instill drops or ointment.
  • Lifestyle and Hygiene Management:   - Do not share towels.   - Avoid using eye makeup while the infection is being treated.   - Clear purulent discharge using a wet cotton ball or a warm washcloth.   - Apply warm compresses to the affected eye.

Ocular Anti-Allergic Drugs: Mast Cell Stabilizers and Antihistamines

  • Mast Cell Stabilizers: These limit hypersensitivity reactions by inhibiting the degranulation of sensitized mast cells. They are typically used to treat vernal conjunctivitis.
  • Antihistamines: These work by blocking the Histamine 11 (H1H1) receptors. They are typically used to treat allergic conjunctivitis.
  • Precautions:   - Can cause hypersensitivity reactions.   - Products containing Benzalkonium chloride can affect soft contact lenses. Patients wearing contacts must be informed.
  • Common ADRs:   - Stinging and burning upon instillation (most common).   - Blurred vision, discomfort, or tearing.
  • Drug Interactions: Mast cell stabilizers and ocular antihistamines typically have no known drug interactions.

Ophthalmic Anti-Inflammatory Agents

  • Classes: Available as Ophthalmic NSAIDs and Ophthalmic Corticosteroid agents.
  • Ocular Corticosteroids Specialist Referral: Any patient requiring ocular corticosteroids must be referred to an ophthalmologist due to severe risks.
  • Naphazoline (Nefazoline): An anti-inflammatory ocular agent that may precipitate narrow-angle glaucoma.
  • Risks of Ocular Corticosteroids:   - Glaucoma (elevated intraocular pressure, optic nerve damage).   - Loss of visual acuity and visual field defects.   - Cataract formation.   - Secondary eye infections or exacerbation of existing infections.   - Perforation of the globe.

Ocular Lubricants and Vasoconstrictors

  • Ocular Lubricants (Artificial Tears):   - Used for relief of dry eyes and irritation.   - Typical usage is 343-4 times per day.   - Warning: Overuse (exceeding a maximum of 44 times a day) can actually exacerbate dry eye symptoms.
  • Ophthalmic Vasoconstrictors:   - Used for temporary relief of redness caused by minor irritants or allergic conjunctivitis.   - Brands: Bausch & Lomb Allergy Drops, Clear Eyes, Comfort Eye Drops.   - Contraindication: Narrow-angle glaucoma.   - Dosing (Adults): 121-2 drops up to a maximum of 44 times daily. Not recommended for children.   - Overuse Warning: Prolonged use can lead to dry eye syndrome.   - Drug Interactions:     - Naphazoline interacts with Tricyclic Antidepressants.     - All ophthalmic vasoconstrictors interact with Monoamine Oxidase Inhibitors (MAOIs) and Beta Blockers.

Fluorescein Eye Stain Procedure

  • Purpose: Used to detect corneal abrasions.
  • Definition: Topical Fluorescein Sodium is a yellow, water-soluble, dibasic acidic xanthine dye.
  • Procedure:   1. Instill 11 or 22 drops of fluorescein solution or use strips moistened with sterile water.   2. Have the patient roll their eyes to coat the surface.   3. Darken the exam room.   4. Use a Woods Lamp (UV light) to examine the eye.
  • Results: Corneal abrasions will glow a bright neon yellow-green. An intact cornea will not stain, though it may show slight yellow discoloration.

Otic Anti-Infectives and Analgesics

  • Combination Products: Medications containing both a corticosteroid and an antibiotic (e.g., Cortisporin, CiproDex, Cipro HC).   - The hydrocortisone (HCHC) component reduces inflammation in the ear canal.   - Primary use: Otitis externa (external ear infection).
  • Contraindication: Do not use any medication with a steroid component if the tympanic membrane is perforated.
  • Antibiotic-only Drops: Gentamicin and Ofloxacin.
  • Otitis Externa Adjuncts: Acid or alcohol drops can be used to dry moisture in the ear canal.
  • Topical Otic Analgesics:   - Agents: Auralgan and Benzocaine.   - Usage: Provide pain relief for Otitis Media.   - Dosing: Instill into the affected ear 343-4 times a day or as often as every 121-2 hours as needed for pain.

Management of Impacted Cerumen

  • Medications: Carbamide peroxide-based products such as Debrox, Dent's Ear Wax, and Murine Ear Wax Removal.
  • Clinical Application: Used to soften earwax prior to irrigation.
  • Clinical Timing: The medication should sit in the ear for at least 152015-20 minutes before irrigation to ensure the wax is soft enough to remove.
  • Home Administration:   - Instill 151-5 drops (depending on canal size) twice daily for up to 44 days.   - Persistent cases: If wax is too hard to remove in-office, patients are sent home with a prescription to use for 44 days before returning for irrigation.